Le Lézard
Classified in: Science and technology
Subjects: Survey, Economic News/Analysis

Global Blue Releases the Monthly Tax Free Shopping Business Update for February 2023


Fresh data from Global Blue shows the recovery for Tax Free Shopping remains solid across Continental Europe and Asia Pacific.

Issued sales in store like-for-like recovery reached 90%1 in February vs. 102%1 in January.

This lower recovery rate in February is the result of a basis of comparison effect, as Mainland Chinese shoppers accounted for 44% of 2019 February sales in store (Chinese New Year season) vs. 34% in the full year of 2019.

The underlying market trends remain strong as all nationalities experienced a similar or improved recovery rate in February vs. January.

A robust recovery in Continental Europe

In Continental Europe, recovery remains strong at 100%1 in February 2023 vs. the same period in 2019. Excluding Mainland China and Russia, the recovery reached 149%1 in February vs. 147%1 in January and 147%1 in Q4'22.

Regarding origin markets, Global Blue data shows a positive momentum across most nationalities. Gulf Cooperation Council citizens have reached a record high level of 286%1 vs. the same period in 2019. US nationals' recovery also remains significantly ahead at 284%1. Excluding Mainland China, Asian shopper recovery remains solid at 112%1.

In terms of destination markets, the Mediterranean countries are at the forefront of the recovery. The recovery was predominantly led by France at 143%1, Portugal at 142%1, Greece at 140%1, Switzerland at 118%1 and Spain at 91%1.

A sustained recovery in Asia Pacific

In Asia Pacific, recovery reached 74%1 in February vs. the same period in 2019. Excluding Mainland China and Russia, the recovery reached 164%1 in February vs. 159%1 in January and 134%1 in Q4'22.

In terms of origin markets, Hong Kong and Taiwan nationals are leading the recovery at 347%1 in February vs. the same period in 2019. This was followed by South East Asia nationals at 149%1, and North East Asia nationals at 142%1.

Regarding destination markets, Japan is leading the recovery with 85%1. After Japan, recovery was closely followed by South Korea and Singapore at 61%1.

A gradual recovery for Mainland Chinese shoppers

Since the reopening of China's border in January, Mainland Chinese shopper recovery has been steadily improving, at 22%1 in Europe and 27%1 in Asia Pacific. Net of Chinese New Year seasonal impact, the recovery reached 33%1 in Continental Europe and 35%1 in Asia Pacific, vs. 17% and 26% respectively in January.

In terms of destination markets, the recovery was predominantly led by France and Germany in Europe, at 31%1 and 30%1 respectively, and by South Korea and Japan in Asia Pacific, at 36%1 and 28%1 respectively (non-restated figures from the Chinese New Year seasonal effect).

In February, Mainland Chinese shoppers' willingness to travel remained strong at 76%2. A gradual recovery is still expected due to limited air capacity. According to ForwardKeys data and Global Blue estimates, the air capacity recovery from Mainland China to Continental Europe and Asia Pacific should reach 25% in Q2, vs. 18% and 10% respectively in February.

APPENDIX

Glossary

- Gulf Cooperation Council countries include: Kuwait, Qatar, Saudi Arabia, United Arab Emirates, Bahrain, Oman
- South East Asia countries include: Indonesia, Thailand, Cambodia, Philippines, Vietnam, Malaysia, Singapore
- North East Asia countries include: Japan, South Korea

YTD Data

Issued SIS L/L recovery1

(in % of 2019)

 

February

2023

 

 

January

2023

 

Q4

2022

Q3

2022

Q2

2022

Q1

2022

Continental
Europe

100%

106%

104%

101%

75%

53%

Asia Pacific

74%

96%

80%

51%

39%

16%

TOTAL

90%

102%

97%

89%

65%

40%

ABOUT GLOBAL BLUE

Global Blue pioneered the concept of Tax Free Shopping 40 years ago. Through continuous innovation, we have become the leading strategic technology and payments partner, empowering retailers to improve their performance and shoppers to enhance their experience.

Global Blue offers innovative solutions in three different fields:

In addition, our data and advisory services offer a strategic advisory to help retailers identify opportunities for growth, while our shopper experience and engagement solutions provide data-driven solutions to increase footfall, convert footfall to revenue and enhance performance.

For more information, visit http://www.globalblue.com/corporate/

Global Blue Monthly Speaker Notes Data, January 2023, Source: Global Blue

1 Recovery rate is equal to 2023 Issued Sales in Store divided by 2019 Issued Sales in Store, like-for-like (i.e.: at constant merchant scope and exchange rates).
2 According to the Global Blue Monthly Travel Sentiment barometer


These press releases may also interest you

at 06:02
With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major...

at 06:00
Amplify10, the trailblazer in SaaS AI-Powered Sales Execution solutions, proudly announces its official launch today, aimed at reshaping the landscape of sales performance for enterprises worldwide. The early-stage company, formerly known as...

at 06:00
Quhuo Limited ("Quhuo" or the "Company") , a leading gig economy platform focusing on local life services in China, today announced that Ms. Chenxi Zhao has resigned from her position as a member of the board of directors (the "Board"), effective on...

at 05:50
NADclinic Group and Bontac Bio-Engineering (Shenzhen) Co., Ltd have officially entered into a dynamic strategic partnership to collaboratively focus on the future of global health and wellness. Synergistically leveraging their collective expertise...

at 05:45
A report from China.org.cn:  China Duty Free Group (CDFG), the world's leading travel retail operator, outlined its strategy for continued growth at the recently concluded TFWA Asia Pacific Exhibition & Conference held in Singapore from May 12 to...

at 05:35
Drug Farm announced today the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application of DF-003, a first-in-class, oral, potent, highly selective alpha-kinase 1 (ALPK1) inhibitor for clinical evaluation in...



News published on and distributed by: